Knowles (KN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
28 Jul, 2026Executive summary
Q2 2026 revenue reached $166.8 million, up 14.3% year-over-year, driven by strong demand in Precision Devices, MedTech, Defense, Industrial, and Electrification markets, surpassing guidance.
Non-GAAP diluted EPS increased 38% year-over-year to $0.33, reflecting higher volume, margin expansion, and lower interest expense.
Net cash from operations was $28.2 million in Q2 2026, with increased working capital to support inventory build.
Book-to-bill ratio exceeded one for the seventh consecutive quarter, indicating strong demand and robust backlog.
Strong organic growth and momentum in new platforms, with multiple new design wins ramping across end markets.
Financial highlights
Q2 2026 gross profit was $74.6 million (44.7% margin), up from $60.6 million (41.5%) in Q2 2025; non-GAAP gross margin improved to 45.4%.
Adjusted EBITDA for Q2 2026 was $41.8 million (25.1% margin), up from $32.7 million (22.4%) year-over-year.
Net earnings for Q2 2026 were $19.4 million, up from $7.8 million in Q2 2025.
Adjusted free cash flow for Q2 2026 was $22.9 million (13.7% of revenues).
Non-GAAP operating expenses were $40.1 million (24.0% margin), up from $36.2 million (24.8% margin) year-over-year.
Outlook and guidance
Q3 2026 revenue expected between $167 million and $177 million, with non-GAAP diluted EPS guidance of $0.34–$0.38.
Q3 2026 net cash from operations projected at $35–$45 million.
Full-year 2026 revenue growth expected at 10–12%, with adjusted EBITDA growth over 20% and capital expenditures about 5% of revenues.
Management anticipates exceeding organic growth targets for 2027 and remaining in compliance with all debt covenants.
Latest events from Knowles
- Transformation drives strong growth, margin expansion, and new opportunities in resilient markets.KN
16th Annual East Coast IDEAS Conference - Q1 2026 revenue rose 16% to $153.1M, with 50% EPS growth and strong segment margins.KN
Q1 2026 - Annual meeting covers director elections, executive pay, and auditor ratification for 2026.KN
Proxy Filing - 2026 proxy covers director elections, executive pay, auditor ratification, and robust governance.KN
Proxy Filing - Q4 and full year 2025 results exceeded guidance, with strong growth and positive 2026 outlook.KN
Q4 2025 - Portfolio shift to MedTech, defense, and industrial boosts margins and growth outlook.KN
2024 Southwest IDEAS Conference - Q3 revenue up 32% year-over-year; strategic divestiture and margin gains position for growth.KN
Q3 2024 - Targets 8–10% annual revenue growth and 10–14% EBITDA growth through organic and M&A strategies.KN
Investor Day 2025 - Q1 2025 revenue hit $132.2M, with strong cash flow and higher Q2 growth expected.KN
Q1 2025